Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy

Clinical trial NCT02292472 · COMPLETED

Trial details

NCT number: NCT02292472
Sponsor: Medy-Tox
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertrophy of Masseter Muscle

Start date: 2014-10-06
Primary completion: 2015-05-24
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.